BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28592924)

  • 1. Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA.
    Wu Q; Wu X; Ying X; Zhu Q; Wang X; Jiang L; Chen X; Wu Y; Wang X
    Cancer Cell Int; 2017; 17():62. PubMed ID: 28592924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophage-derived exosomal microRNA-155-5p stimulates intracranial aneurysm formation and macrophage infiltration.
    Feng Z; Zhang X; Li L; Wang C; Feng M; Zhao K; Zhao R; Liu J; Fang Y
    Clin Sci (Lond); 2019 Nov; 133(22):2265-2282. PubMed ID: 31657855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
    Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis.
    Cheng C; Zhang Z; Cheng F; Shao Z
    Onco Targets Ther; 2020; 13():3291-3301. PubMed ID: 32368088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of CD163
    Zhang X; Wang J; Liu N; Wu W; Li H; Chen J; Guo X
    Ann Transl Med; 2022 Sep; 10(18):1014. PubMed ID: 36267748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Lin YY; Hua KQ
    Int J Biol Sci; 2018; 14(14):1960-1973. PubMed ID: 30585260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]   [Full Text] [Related]  

  • 9. Exosomal miR-183-5p Shuttled by M2 Polarized Tumor-Associated Macrophage Promotes the Development of Colon Cancer
    Zhang S; Li D; Zhao M; Yang F; Sang C; Yan C; Wang Z; Li Y
    Front Oncol; 2021; 11():672684. PubMed ID: 34249713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis].
    Zhou SK; Gao F; Zhong ZS; Yao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):944-951. PubMed ID: 33036509
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell.
    Zhou W; Ma J; Zhao H; Wang Q; Guo X; Chen L; Cao Z; Xu J; Zhang B; Zhou X
    Mol Cell Proteomics; 2023 Apr; 22(4):100520. PubMed ID: 36842607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.
    Li T; Lin L; Liu Q; Gao W; Chen L; Sha C; Chen Q; Xu W; Li Y; Zhu X
    Am J Cancer Res; 2021; 11(5):2124-2141. PubMed ID: 34094673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
    Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
    Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L
    Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.
    Chen X; Ying X; Wang X; Wu X; Zhu Q; Wang X
    Oncol Rep; 2017 Jul; 38(1):522-528. PubMed ID: 28586039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Atrial Fibrillation-Derived Exosome Delivery of miR-107 to Human Umbilical Vein Endothelial Cells.
    Wang S; Li L; Hu X; Liu T; Jiang W; Wu R; Ren Y; Wang M
    DNA Cell Biol; 2021 Apr; 40(4):568-579. PubMed ID: 33651959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
    Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
    J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived exosomal circRNA051239 promotes proliferation and migration of epithelial ovarian cancer.
    Ma R; Ye X; Cheng H; Cui H; Chang X
    Am J Transl Res; 2021; 13(3):1125-1139. PubMed ID: 33841644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of exosome-derived miR-223 from macrophages on the metastasis of gastric cancer cells].
    Zheng PM; Gao HJ; Li JM; Zhang P; Li G
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(22):1750-1755. PubMed ID: 32536099
    [No Abstract]   [Full Text] [Related]  

  • 20. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.
    Ying X; Wu Q; Wu X; Zhu Q; Wang X; Jiang L; Chen X; Wang X
    Oncotarget; 2016 Jul; 7(28):43076-43087. PubMed ID: 27172798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.